Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Obstructive Sleep Apnea and Risk of Motor Vehicle Crash: Systematic Review and Meta-Analysis
2009492 citationsStephen Tregear, James Reston et al.profile →
AHRQ Series Paper 5: Grading the strength of a body of evidence when comparing medical interventions—Agency for Healthcare Research and Quality and the Effective Health-Care Program
2009417 citationsDouglas K Owens, Kathleen N Lohr et al.Journal of Clinical Epidemiologyprofile →
This map shows the geographic impact of James Reston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Reston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Reston more than expected).
This network shows the impact of papers produced by James Reston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Reston. The network helps show where James Reston may publish in the future.
Co-authorship network of co-authors of James Reston
This figure shows the co-authorship network connecting the top 25 collaborators of James Reston.
A scholar is included among the top collaborators of James Reston based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with James Reston. James Reston is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Reston, James & Karen M Schoelles. (2013). In-Facility Delirium Prevention Programs as a Patient Safety Strategy. Annals of Internal Medicine.2 indexed citations
5.
Bruening, Wendy, Stacey Uhl, Joann Fontanarosa, et al.. (2012). Noninvasive Diagnostic Tests for Breast Abnormalities.1 indexed citations
6.
Bruening, Wendy, et al.. (2012). Noninvasive Diagnostic Tests for Breast Abnormalities: Update of a 2006 Review. Europe PMC (PubMed Central).11 indexed citations
Oyesanmi, Olu, David Snyder, Nancy Sullivan, et al.. (2010). Alcohol consumption and cancer risk: understanding possible causal mechanisms for breast and colorectal cancers.. PubMed. 1–151.28 indexed citations
10.
Owens, Douglas K, Kathleen N Lohr, David C. Atkins, et al.. (2009). Grading the Strength of a Body of Evidence When Comparing Medical Interventions. Journal of Clinical Epidemiology.30 indexed citations
11.
Owens, Douglas K, Kathleen N Lohr, David C. Atkins, et al.. (2009). AHRQ Series Paper 5: Grading the strength of a body of evidence when comparing medical interventions—Agency for Healthcare Research and Quality and the Effective Health-Care Program. Journal of Clinical Epidemiology. 63(5). 513–523.417 indexed citations breakdown →
Rossiter, Clinton, et al.. (1960). The National purpose. Holt, Rinehart and Winston eBooks.3 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.